ELSOHLY LABORATORIES, INC.

Biotech · Private

Manufacturing process for large-scale isolation and purification of THC and CBD cannabinoids from cannabis extracts using protected amino acid ester derivatization and chromatographic separation

Grants
$363K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · An Opioid/Cannabinoid Analgesic that Boosts Pain Relief and Blocks Opiate Reward$180,830
Federal grantDepartment of Health and Human Services · Phase I · Development of a Process for GMP Production of Natural THC and CBD$182,361
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3062Centessa Pharmaceuticals——
3063Entrega——
3064Nested Therapeutics——
3065ELSOHLY LABORATORIES, INC.——
3066490 BIOTECH INC——
3067Synthis Therapeutics, Inc.——
3068Ottimo Pharma——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.